Medical Xpress September 25, 2024
German Cancer Research Center

Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However, particularly in the case of genetic variants that only rarely occur in the population, the influence on the presentation of certain pathological traits has so far been difficult to determine.

Researchers from the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL) and the Technical University of Munich have introduced an algorithm based on that can predict the effects of rare genetic variants.

The paper, “Integration of Variant annotations using deep set networks boosts rare testing,” has been published in Nature Medicine .

The method allows persons with high risk of disease to be distinguished...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
What McKinsey learned while creating its generative AI platform
Gen Z are all using AI to get their work done, study finds
Microsoft’s 10 new AI agents strengthen its enterprise automation lead
Learning the Language of Life with A.I.
How Payers are Using AI to Deny Claims and Dent Provider Revenue

Share This Article